Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2025-04-22 Environmental & Social …
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2024年度可持续发展报告
Environmental & Social Information Classification · 95% confidence The document is titled '2024年度可持续发展报告' which translates to '2024 Annual Sustainability Report'. It contains detailed sections on corporate governance, environmental protection, social responsibility, product safety and quality, sustainable development management, and human capital management. The report references ESG (Environmental, Social, and Governance) management frameworks and includes extensive narrative on sustainability practices, risk management, stakeholder communication, and company culture. It is a comprehensive report focused on the company's performance and initiatives related to environmental and social governance factors rather than financial results or regulatory filings. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, the document fits the category of Environmental & Social Information (ESG) report.
2025-04-22 Chinese
2025年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2025 First Quarter Report" of Shenzhen Huitai Medical Device Co., Ltd. It contains detailed financial data for the first quarter of 2025, including income, net profit, cash flow, earnings per share, and balance sheet items. The report explicitly states it is a quarterly report and includes unaudited financial statements. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. There is no indication that this is merely an announcement or a certification, and the document length and content support it being the full report itself. Q1 2025
2025-04-22 Chinese
2024年度内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report' for the fiscal year 2024. It includes an audit opinion on the effectiveness of the company's internal control over financial reporting as of December 31, 2024. The document references auditing standards and responsibilities of the company and auditors, typical of an audit report. The length is 2530 characters, which is relatively short but the content is a standalone audit report rather than an announcement or certification. It does not contain full annual financial statements or comprehensive annual report content, so it is not a 10-K or Annual Report. It is not a certification letter or a brief announcement, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the best fit is Audit Report / Information (AR). FY 2024
2025-04-22 Chinese
2024年度独立董事述职报告（夏立军）
Board/Management Information Classification · 95% confidence The document is titled as the "2024年度独立董事述职报告" which translates to "2024 Annual Independent Director's Work Report". It details the independent director's activities, attendance at board and committee meetings, oversight of financial reports, audit committee work, and other governance-related duties during the 2024 fiscal year. The content focuses on the independent director's role, supervision, and evaluation of company governance and financial reporting, rather than presenting full financial statements or comprehensive financial performance data. It is a detailed management-related report on the independent director's duties and observations, not a full annual report or audit report. This fits best under the category of Board/Management Information (MANG), which covers announcements or reports related to board or senior management activities and changes. The document is not a financial report, earnings release, or regulatory filing, but a management report from an independent director. Therefore, the classification is MANG with high confidence.
2025-04-22 Chinese
股东会议事规则
Governance Information Classification · 95% confidence The document is titled as "股东会议事规则" which translates to "Rules of Procedure for Shareholders' Meetings" for Shenzhen Huitai Medical Devices Co., Ltd. It details the procedures, legal basis, and regulations for convening and conducting shareholders' meetings, including rights, voting procedures, proposal submissions, and meeting conduct. There is no financial data, earnings information, or report content. It is a governance-related document outlining internal rules and procedures for shareholder meetings. Therefore, it fits best under Governance Information (CGR). The document length is sufficient and it is not an announcement or a brief notice, but a detailed procedural document.
2025-04-22 Chinese
关于召开2024年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of Shenzhen Huitai Medical Devices Co., Ltd. It includes the date, voting methods, agenda items for shareholder approval, registration details, and proxy voting instructions. The document references the 2024 annual report and financial statements as agenda items to be approved at the meeting but does not contain the reports themselves. The content is typical of an AGM notice or invitation rather than the actual annual report or financial statements. The document length is about 5,028 characters, which is consistent with a detailed meeting notice. Therefore, this document fits the category of AGM Information (AGM-R).
2025-04-22 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.